journal article·2024-08Open access

Friend or foe? Inflammation and the foreign body response to orthopedic biomaterials

Emmanuel Gibon, Yuya Takakubo, Stefan Zwingenberger, Jiri Gallo, Michiaki Takagi, Stuart B. Goodman

Abstract

Abstract The use of biomaterials and implants for joint replacement, fracture fixation, spinal stabilization and other orthopedic indications has revolutionized patient care by reliably decreasing pain and improving function. These surgical procedures always invoke an acute inflammatory reaction initially, that in most cases, readily subsides. Occasionally, chronic inflammation around the implant develops and persists; this results in unremitting pain and compromises function. The etiology of chronic inflammation may be specific, such as with infection, or be unknown. The histological hallmarks of chronic inflammation include activated macrophages, fibroblasts, T cell subsets, and other cells of the innate immune system. The presence of cells of the adaptive immune system usually indicates allergic reactions to metallic haptens. A foreign body reaction is composed of activated macrophages, giant cells, fibroblasts, and other cells often distributed in a characteristic histological arrangement; this reaction is usually due to particulate debris and other byproducts from the biomaterials used in the implant. Both chronic inflammation and the foreign body response have adverse biological effects on the integration of the implant with the surrounding tissues. Strategies to mitigate chronic inflammation and the foreign body response will enhance the initial incorporation and longevity of the implant, and thereby, improve long‐term pain relief and overall function for the patient. The seminal research performed in the laboratory of Dr. James Anderson and co‐workers has provided an inspirational and driving force for our laboratory's work on the interactions and crosstalk among cells of the mesenchymal, immune, and vascular lineages, and orthopedic biomaterials. Dr. Anderson's delineation of the fundamental biologic processes and mechanisms underlying acute and chronic inflammation, the foreign body response, resolution, and eventual functional integration of implants in different organ systems has provided researchers with a strategic approach to the use of biomaterials to improve health in numerous clinical scenarios.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Orthopedic Infections and Treatments · Bone fractures and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedic Surgery University of Pennsylvania Philadelphia Pennsylvania USA

Department of Rehabilitation Yamagata University, Faculty of Medicine Yamagata Japan

University Center for Orthopaedics, Traumatology, and Plastic Surgery University Hospital Carl Gustav Carus at Technische Universität Dresden Dresden Germany

Department of Orthopaedics, Faculty of Medicine and Dentistry Palacky University Olomouc Teaching Hospital Olomouc Czech Republic

Department of Orthopaedic Surgery Yamagata University Faculty of Medicine Yamagata Japan

Department of Orthopaedic Surgery and (by courtesy) Bioengineering Stanford University Medical Center Outpatient Center California USA

References (100+)

Show source-provided references
1. 10.1186/1476-9255-1-110.1186/1476-9255-1-1 ↗
2. 10.1002/eji.20083885510.1002/eji.200838855 ↗
3. 10.1016/B978-0-12-816137-1.00048-910.1016/B978-0-12-816137-1.00048-9 ↗
4. 10.1172/JCI9794310.1172/JCI97943 ↗
5. 10.1002/jbm.a.3528010.1002/jbm.a.35280 ↗
6. 10.1146/annurev-immunol-032712-10002210.1146/annurev-immunol-032712-100022 ↗
7. 10.1002/jbm.a.3221810.1002/jbm.a.32218 ↗
8. Polymorphonuclear leukocyte inhibition of monocytes/macrophages in the foreign body reaction10.1002/jbm.a.32682 ↗
9. 10.1002/jbm.b.3367610.1002/jbm.b.33676 ↗
10. 10.1002/jbm.b.3373410.1002/jbm.b.33734 ↗
11. Services USDoHaH · 2023
12. 10.2106/JBJS.17.0161710.2106/JBJS.17.01617 ↗
13. 10.1016/j.arth.2020.02.03010.1016/j.arth.2020.02.030 ↗
14. AAOS.The AJRR Annual Report.2022.
15. 10.1038/nrrheum.2012.110.1038/nrrheum.2012.1 ↗
16. 10.1359/jbmr.2002.17.3.51310.1359/jbmr.2002.17.3.513 ↗
17. Rüedi TP · 2007
18. General OotS · 2004
19. 10.1189/jlb.060636510.1189/jlb.0606365 ↗
20. 10.1189/jlb.081044610.1189/jlb.0810446 ↗
21. Macrophages in bone fracture healing: their essential role in endochondral ossification
22. 10.1007/s11914-022-00720-310.1007/s11914-022-00720-3 ↗
23. 10.1146/annurev-physiol-022516-03433910.1146/annurev-physiol-022516-034339 ↗
24. 10.1038/ni.270510.1038/ni.2705 ↗
25. 10.1016/j.biomaterials.2021.12112710.1016/j.biomaterials.2021.121127 ↗
26. 10.1615/JLongTermEffMedImplants.201401135510.1615/JLongTermEffMedImplants.2014011355 ↗
27. Kyriakides TR · 2022 · 022007
28. 10.1007/s10439-021-02832-w10.1007/s10439-021-02832-w ↗
29. 10.1002/jbm.a.3497210.1002/jbm.a.34972 ↗
30. 10.1016/j.actbio.2012.03.04210.1016/j.actbio.2012.03.042 ↗
31. 10.1016/j.ajpath.2014.11.00810.1016/j.ajpath.2014.11.008 ↗
32. 10.1016/j.jri.2008.01.00110.1016/j.jri.2008.01.001 ↗
33. 10.1084/jem.2008204810.1084/jem.20082048 ↗
34. 10.1159/00004789310.1159/000047893 ↗
35. 10.1016/j.injury.2005.07.02710.1016/j.injury.2005.07.027 ↗
36. 10.3109/s10165-010-0357-810.3109/s10165-010-0357-8 ↗
37. 10.1002/jor.2355310.1002/jor.23553 ↗
38. 10.1073/pnas.101850110810.1073/pnas.1018501108 ↗
39. 10.1359/jbmr.2003.18.9.158410.1359/jbmr.2003.18.9.1584 ↗
40. 10.1302/0301-620X.82B5.082065510.1302/0301-620X.82B5.0820655 ↗
41. 10.1242/dmm.00318610.1242/dmm.003186 ↗
42. 10.1002/jcb.1043510.1002/jcb.10435 ↗
43. 10.1359/jbmr.2001.16.6.100410.1359/jbmr.2001.16.6.1004 ↗
44. 10.1186/s13287-016-0276-510.1186/s13287-016-0276-5 ↗
45. 10.1002/stem.104010.1002/stem.1040 ↗
46. 10.1371/journal.pone.003987110.1371/journal.pone.0039871 ↗
47. 10.1007/s00441-017-2598-810.1007/s00441-017-2598-8 ↗
48. 10.1089/dna.2021.086910.1089/dna.2021.0869 ↗
49. 10.1155/2021/883515610.1155/2021/8835156 ↗
50. 10.1089/ten.teb.2020.015410.1089/ten.teb.2020.0154 ↗
51. 10.1177/15440591080870021510.1177/154405910808700215 ↗
52. 10.1016/S1359-6446(03)02866-610.1016/S1359-6446(03)02866-6 ↗
53. 10.1126/science.abi520010.1126/science.abi5200 ↗
54. 10.1016/j.cell.2015.02.01010.1016/j.cell.2015.02.010 ↗
55. 10.1172/JCI9795010.1172/JCI97950 ↗
56. 10.1016/j.cell.2010.02.02910.1016/j.cell.2010.02.029 ↗
57. 10.1038/s41584-022-00905-110.1038/s41584-022-00905-1 ↗
58. 10.1016/j.immuni.2022.03.01610.1016/j.immuni.2022.03.016 ↗
59. 10.1016/j.arth.2019.05.02510.1016/j.arth.2019.05.025 ↗
60. 10.1016/j.knee.2015.02.00710.1016/j.knee.2015.02.007 ↗
61. 10.1016/j.actbio.2014.02.00310.1016/j.actbio.2014.02.003 ↗
62. 10.1002/jbm.b.3502310.1002/jbm.b.35023 ↗
63. 10.1302/2058-5241.6.21001310.1302/2058-5241.6.210013 ↗
64. 10.1302/0301-620X.80B3.080053110.1302/0301-620X.80B3.0800531 ↗
65. 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L ↗
66. 10.1080/17453674.2017.136277410.1080/17453674.2017.1362774 ↗
67. 10.1146/annurev-immunol-032712-09593710.1146/annurev-immunol-032712-095937 ↗
68. 10.1073/pnas.220496711910.1073/pnas.2204967119 ↗
69. 10.1089/ten.tec.2017.016610.1089/ten.tec.2017.0166 ↗
70. 10.1002/jor.2497710.1002/jor.24977 ↗
71. 10.1002/1529-0131(200104)44:4<956::AID-ANR153>3.0.CO;2-310.1002/1529-0131(200104)44:4<956::AID-ANR153>3.0.CO;2-3 ↗
72. 10.1016/j.prp.2014.09.01710.1016/j.prp.2014.09.017 ↗
73. 10.1016/j.arth.2018.03.03910.1016/j.arth.2018.03.039 ↗
74. 10.1016/j.arth.2022.12.01510.1016/j.arth.2022.12.015 ↗
75. 10.1016/j.smim.2007.11.00410.1016/j.smim.2007.11.004 ↗
76. 10.1002/jbm.a.3595810.1002/jbm.a.35958 ↗
77. 10.1002/jbm.b.3399010.1002/jbm.b.33990 ↗
78. 10.1002/jor.2532610.1002/jor.25326 ↗
79. 10.1038/s41577-021-00540-z10.1038/s41577-021-00540-z ↗
80. 10.1126/sciadv.add001410.1126/sciadv.add0014 ↗
81. 10.1186/s13018-019-1119-810.1186/s13018-019-1119-8 ↗
82. 10.1002/btm2.1030010.1002/btm2.10300 ↗
83. 10.1146/annurev-immunol-101320-03155510.1146/annurev-immunol-101320-031555 ↗
84. 10.3389/fimmu.2022.102141310.3389/fimmu.2022.1021413 ↗
85. 10.1002/jor.2504010.1002/jor.25040 ↗
86. 10.1016/j.actbio.2022.02.00710.1016/j.actbio.2022.02.007 ↗
87. 10.1016/j.actbio.2013.06.02710.1016/j.actbio.2013.06.027 ↗
88. 10.1302/0301-620X.81B1.081015510.1302/0301-620X.81B1.0810155 ↗
89. 10.1016/S0142-9612(98)00140-910.1016/S0142-9612(98)00140-9 ↗
90. 10.1016/S0142-9612(99)00261-610.1016/S0142-9612(99)00261-6 ↗
91. 10.1302/2046-3758.108.BJR-2021-0058.R110.1302/2046-3758.108.BJR-2021-0058.R1 ↗
92. 10.5507/bp.2020.01910.5507/bp.2020.019 ↗
93. Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases
94. Immunology of chronic low‐grade inflammation: relationship with metabolic function
95. 10.1152/ajpcell.00181.202010.1152/ajpcell.00181.2020 ↗
96. 10.1096/fj.201801017R10.1096/fj.201801017R ↗
97. 10.1016/j.immuni.2018.07.01510.1016/j.immuni.2018.07.015 ↗
98. 10.3389/fimmu.2021.65277110.3389/fimmu.2021.652771 ↗
99. 10.1038/s41590-022-01387-910.1038/s41590-022-01387-9 ↗
100. 10.1111/febs.1626610.1111/febs.16266 ↗